Jeffrey L. Wade
2012
In 2012, Jeffrey L. Wade earned a total compensation of $1.1M as Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer at Lexicon Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $426,972 |
| Salary | $385,000 |
| Stock Awards | $140,400 |
| Other | $6,804 |
| Total | $1,059,176 |
Wade received $427K in option awards, accounting for 40% of the total pay in 2012.
Wade also received $100K in bonus, $385K in salary, $140.4K in stock awards and $6.8K in other compensation.
Rankings
In 2012, Jeffrey L. Wade's compensation ranked 5,896th out of 11,487 executives tracked by ExecPay. In other words, Wade earned more than 48.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,896 out of 11,487 | 49th |
Division Manufacturing | 2,087 out of 4,253 | 51st |
Major group Chemicals And Allied Products | 521 out of 1,203 | 57th |
Industry group Drugs | 354 out of 925 | 62nd |
Industry Pharmaceutical Preparations | 278 out of 700 | 60th |
Source: SEC filing on March 13, 2015.
Wade's colleagues
We found four more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2012.
2012
Arthur Sands
Lexicon Pharmaceuticals
Chief Executive Officer
2012
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2012
Alan Main
Lexicon Pharmaceuticals
Executive Vice President, CMC and Supply Operations
2012
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019